The Economic Times
In a guest column for The Economic Times, BCG’s Rishabh Bindlish, Anirudh Tara, and Pooja Rajdev examine the potential for Generative AI (GenAI) to transform the health care industry. Many pharmaceutical giants are using GenAI to drastically reduce new drug and therapy development cycle time, enhance clinical decision-making and patient interaction, and improve regulatory compliance efficiency. “With democratized access to AI, new entrants will face fewer barriers, and existing competitors will become more efficient, but the gap between early adopters and laggards will widen,” note the authors.